不同剂量去甲氧柔红霉素联合阿糖胞苷诱导治疗年轻初发急性髓系白血病的疗效和安全性分析

OBJECTIVE: To compare the efficacy, safety and long-term prognosis between different dose idarubicin (IDA) combined with cytarabine (IA) as induction chemotherapy in newly diagnosed young patients of acute myeloid leukemia (AML). METHODS: A total of 149 newly diagnosed young AML patients (APL exclud...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Zhonghua Xue Ye Xue Za Zhi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Editorial office of Chinese Journal of Hematology 2016
Pynciau:
论著
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7348532/
https://ncbi.nlm.nih.gov/pubmed/27587250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.08.010
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg